We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$701K
Cap. Flow
-$16.4M
Cap. Flow %
-8.91%
Top 10 Hldgs %
51.23%
Holding
107
New
12
Increased
18
Reduced
32
Closed
25

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.89M
2
BABA icon
Alibaba
BABA
+$1.31M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.09M
4
LFCR icon
Lifecore Biomedical
LFCR
+$965K
5
YETI icon
Yeti Holdings
YETI
+$443K

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$2.33M
2
ABBV icon
AbbVie
ABBV
+$1.75M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.28M
4
T icon
AT&T
T
+$1M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$986K

Sector Composition

Rank Sector Weight
1 Healthcare 32.01%
2 Technology 17.2%
3 Communication Services 6.8%
4 Consumer Discretionary 4.09%
5 Financials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOD
26
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.11M 1.14%
261,500
+8,000
+3% +$61.1K
AMGN icon
27
Amgen
AMGN
$208B
$2.02M 1.09%
7,000
-1,400
-17% -$381K
LFCR icon
28
Lifecore Biomedical
LFCR
$166M
$1.61M 0.87%
259,684
+138,930
+115% +$965K
GM icon
29
General Motors
GM
$80.4B
$1.44M 0.78%
40,000
-4,000
-9% -$124K
OI icon
30
O-I Glass
OI
$1.1B
$1.36M 0.74%
83,250
+24,000
+41% +$370K
T icon
31
AT&T
T
$159B
$1.33M 0.72%
79,000
-63,500
-45% -$1M
B
32
Barrick Mining
B
$61.5B
$1.31M 0.71%
72,500
+20,000
+38% +$328K
ALT icon
33
Altimmune
ALT
$552M
$1.3M 0.7%
115,225
-4,750
-4% -$19.8K
CSCO icon
34
Cisco
CSCO
$457B
$1.26M 0.69%
25,000
+2,500
+11% +$128K
GLD icon
35
CALL
SPDR Gold Trust
GLD
$131B
$1.24M 0.67%
+6,500
New +$1.19M
QCOM icon
36
Qualcomm
QCOM
$155B
$1.23M 0.67%
8,500
– –
F icon
37
Ford
F
$58.5B
$1.22M 0.66%
100,000
– –
ALT icon
38
CALL
Altimmune
ALT
$552M
$1.17M 0.63%
104,000
+5,000
+5% +$20.9K
BABA icon
39
PUT
Alibaba
BABA
$293B
$1.16M 0.63%
+15,000
New +$1.2M
BUR icon
40
Burford Capital
BUR
$903M
$1.13M 0.62%
72,750
+13,750
+23% +$184K
FXI icon
41
CALL
iShares China Large-Cap ETF
FXI
$4.37B
$1.12M 0.61%
+46,500
New +$1.18M
SLV icon
42
iShares Silver Trust
SLV
$28B
$1.09M 0.59%
50,000
– –
MRVL icon
43
Marvell Technology
MRVL
$168B
$1.06M 0.57%
17,500
– –
BOXX icon
44
Alpha Architect 1-3 Month Box ETF
BOXX
$13.1B
$1.04M 0.56%
9,875
+2,375
+32% +$248K
INTC icon
45
Intel
INTC
$455B
$942K 0.51%
18,750
-4,750
-20% -$193K
BIDU icon
46
CALL
Baidu
BIDU
$37.7B
$893K 0.48%
+7,500
New +$867K
LNSR icon
47
LENSAR
LNSR
$61.5M
$844K 0.46%
240,534
-42,002
-15% -$104K
STEW
48
SRH Total Return Fund
STEW
$1.79B
$818K 0.44%
59,000
– –
PAAS icon
49
Pan American Silver
PAAS
$18.2B
$735K 0.4%
45,000
– –
META icon
50
Meta Platforms (Facebook)
META
$1.42T
$708K 0.38%
2,000
– –
1
2
3 4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, DCF Advisers held 107 positions worth $184M, up 0.38% from $184M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers withdrew a net $16.4M in Q4 2023, closing 25 positions and reducing 32 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Yeti Holdings worth $518K.

  • DCF Advisers's largest Q4 2023 buy was Yeti Holdings: 10,000 shares worth $518K.
  • DCF Advisers added most to Revance Therapeutics, Inc. in Q4 2023, an estimated $1.89M increase.
  • DCF Advisers's biggest Q4 2023 reduction was AbbVie, cutting an estimated $1.75M.
  • DCF Advisers fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $2.33M.
  • DCF Advisers's ten largest holdings make up 51% of its $184M portfolio in Q4 2023.
  • DCF Advisers opened 12 new positions and closed 25 in Q4 2023.
  • DCF Advisers's portfolio value rose 0.38% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.